Meiqi Li
No. 78 Hengzhigang Road, Yuexiu District
Guangzhou, 510095, China
Guangzhou, 510095, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT.
Journal: Oncology research
Published: November 13, 2024
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Journal: Cancer research
Published: June 20, 2023
Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 23, 2022
A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer.
Journal: Frontiers in oncology
Published: July 06, 2021
Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.
Journal: Theranostics
Published: April 16, 2020
Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: May 16, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026